Inventor · disambiguated record
Girish G. Kore
Also filed as: KORE GIRISH G
12 granted patents·10 pending applications·48 citations·filing 2019–2025
88Inventor score
Technology areasA61K
Top patents by PatentIndex Score
22 records- 0197US10874671B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Dec 29, 2020·17 cites·23 claims
- 0296US11679105B1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Jun 20, 2023·11 cites·13 claims
- 0396US11590122B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Granted Feb 28, 2023·14 cites·12 claims
- 0494US12357627B2Pharmaceutical compositions of cabozantinibAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Jul 15, 2025·2 cites·18 claims
- 0593US12138255B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·2 cites·6 claims
- 0692US11793809B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Oct 24, 2023·2 cites·9 claims
- 0784US12403140B2Pharmaceutical compositions of nilotinibAZURITY PHARMACEUTICALS INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 0882US2025302819A1Pharmaceutical compositions of cabozantinibAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0981US2025332165A1Pharmaceutical compositions of nilotinibAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1078US12343330B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2023·Granted Jul 1, 2025·0 cites·27 claims
- 1177US2024131018A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 1276US12491178B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Granted Dec 9, 2025·0 cites·18 claims
- 1374US2025082617A1Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 1472US2022387418A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 1571US12194028B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2023·Granted Jan 14, 2025·0 cites·16 claims
- 1671US2025235431A1Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 1770US2025248987A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 1867US11103502B2Pharmaceutical compositions of lurasidoneSLAYBACK PHARMA LLC·Filed 2019·Granted Aug 31, 2021·0 cites·7 claims
- 1959US11103503B2Pharmaceutical compositions of LurasidoneSLAYBACK PHARMA LLC·Filed 2020·Granted Aug 31, 2021·0 cites·12 claims
- 2059US2024189229A1Liquid pharmaceutical compositions of baclofen for oral administrationANI PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2159US2022362235A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 2259US2022280500A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Girish G. Kore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →